-
EP3378471
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3378471
| EP3378471 - HIGH-SWELLING SUSTAINED-RELEASE TRIPLE TABLET CONTAINING PREGABALIN [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 08.08.2024 Database last updated on 24.08.2024 | |
| Former | Examination is in progress Status updated on 20.08.2021 | ||
| Former | Request for examination was made Status updated on 24.08.2018 | ||
| Former | The international publication has been made Status updated on 11.08.2018 | ||
| Former | unknown Status updated on 11.08.2017 | Most recent event Tooltip | 08.08.2024 | Application deemed to be withdrawn | published on 11.09.2024 [2024/37] | Applicant(s) | For all designated states GL Pharmtech Co., Ltd. 714 Chungang Induspia 5th Sangdaewon-dong Jungwon-gu Seongnam, Gyeonggi 462-807 / KR | [2018/39] | Inventor(s) | 01 /
KIM, Kyung Hun 714 Jungang Induspia 5th 137 Sagimakgol-ro Jungwon-gu Seongnam-si Gyeonggi-do 13202 / KR | 02 /
LEE, Kyung Soo 714 Jungang Induspia 5th 137 Sagimakgol-ro Jungwon-gu Seongnam-si Gyeonggi-do 13202 / KR | 03 /
SONG, Woo Heon 714 Jungang Induspia 5th 137 Sagimakgol-ro Jungwon-gu Seongnam-si Gyeonggi-do 13202 / KR | 04 /
PARK, Jun Sang 714 Jungang Induspia 5th 137 Sagimakgol-ro Jungwon-gu Seongnam-si Gyeonggi-do 13202 / KR | [2018/39] | Representative(s) | Walcher, Armin Louis Pöhlau Lohrentz Patentanwälte Partnerschaft mbB Merianstraße 26 90409 Nürnberg / DE | [N/P] |
| Former [2018/39] | Walcher, Armin Louis, Pöhlau, Lohrentz Patentanwälte Postfach 30 55 90014 Nürnberg / DE | Application number, filing date | 17745958.3 | 29.03.2017 | [2018/39] | WO2017KR03378 | Priority number, date | KR20170014591 | 01.02.2017 Original published format: KR 20170014591 | [2018/39] | Filing language | KO | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018143512 | Date: | 09.08.2018 | Language: | KO | [2018/32] | Type: | A1 Application with search report | No.: | EP3378471 | Date: | 26.09.2018 | Language: | EN | [2018/39] | Search report(s) | International search report - published on: | KR | 09.08.2018 | (Supplementary) European search report - dispatched on: | EP | 13.08.2019 | Classification | IPC: | A61K9/24, A61K9/20, A61K9/00, A61K31/197 | [2018/39] | CPC: |
A61K9/209 (EP,KR,US);
A61K31/197 (EP,KR,US);
A61K9/0053 (KR);
A61K9/0065 (EP,US);
A61K9/2013 (KR);
A61K9/2022 (KR);
A61K9/2027 (US);
A61K9/2031 (EP,US);
A61K9/2054 (EP,US);
A61K9/2086 (EP,US);
A61P25/00 (EP);
A61P25/08 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/39] | Title | German: | PREGABALINHALTIGE, HOCH QUELLFÄHIGE, DREISCHICHTIGE TABLETTE MIT VERZÖGERTER FREISETZUNG | [2018/39] | English: | HIGH-SWELLING SUSTAINED-RELEASE TRIPLE TABLET CONTAINING PREGABALIN | [2018/39] | French: | COMPRIMÉ TRIPLE À LIBÉRATION PROLONGÉE ET À GONFLEMENT ÉLEVÉ CONTENANT DE LA PRÉGABALINE | [2018/39] | Entry into regional phase | 10.08.2017 | Translation filed | 10.08.2017 | National basic fee paid | 10.08.2017 | Search fee paid | 10.08.2017 | Designation fee(s) paid | 10.08.2017 | Examination fee paid | Examination procedure | 10.08.2017 | Examination requested [2018/39] | 10.08.2017 | Date on which the examining division has become responsible | 06.03.2020 | Amendment by applicant (claims and/or description) | 23.08.2021 | Despatch of a communication from the examining division (Time limit: M06) | 03.02.2022 | Reply to a communication from the examining division | 22.12.2023 | Despatch of a communication from the examining division (Time limit: M04) | 23.04.2024 | Application deemed to be withdrawn, date of legal effect [2024/37] | 15.05.2024 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2024/37] | Fees paid | Renewal fee | 26.02.2019 | Renewal fee patent year 03 | 22.01.2020 | Renewal fee patent year 04 | 25.01.2021 | Renewal fee patent year 05 | 31.03.2022 | Renewal fee patent year 06 | 21.03.2023 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 31.03.2024 | 08 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2013015578 (YUHAN CORP [KR], et al) [I] 1-8* example - * | International search | [Y]KR20130023127 (KUNWHA PHARMACEUTICAL CO LTD [KR]) [Y] 1-8 * See abstract; paragraph [0036]; table 7; and claims 1-7 *; | [Y]KR20080073989 (GL PHARMTECH CORP [KR]) [Y] 1-8 * See abstract; paragraphs [0024], [0025]; and claims 1-11. *; | [A]KR20140003376 (RATIOPHARM GMBH [DE]) [A] 1-8 * See the entire document. *; | [A]KR20110046360 (CHEILJEDANG CORPORATION) [A] 1-8 * See the entire document. *; | [A]KR20130121717 (CJ CHEILJEDANG CORP [KR]) [A] 1-8 * See the entire document. * | by applicant | US5563175 | USRE41920E |